Journal article : Letter

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran

Publication status:: Published

Peer review status:: Reviewed (other)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Ghafari, M., Kadivar, A., & Katzourakis, A. (2021). Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran. Lancet Infectious Diseases, 21(5), 602–603.

MLA Style

Ghafari, M., et al. “Estimates of Anti-SARS-CoV-2 Antibody Seroprevalence in Iran.” Lancet Infectious Diseases, vol. 21, no. 5, Elsevier, 2021, pp. 602–03.

Chicago Style

Ghafari, M, A Kadivar, and A Katzourakis. 2021. “Estimates of Anti-SARS-CoV-2 Antibody Seroprevalence in Iran.” Lancet Infectious Diseases 21 (5): 602–3.
Share
Print

Access Document

Publisher copy:: 10.1016/s1473-3099(21)00053-0

Authors

+ Ghafari, M More by this author

Institution:: University of Oxford
Role:: Author

+ Kadivar, A More by this author

Role:: Author

+ Katzourakis, A More by this author

Institution:: University of Oxford
Department:: ZOOLOGY
Sub department:: Zoology
Oxford college:: St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; St Hildas College; ST HILDAS COLLEGE
Role:: Author

Publisher:: Elsevier
Journal:: Lancet Infectious Diseases More from this journal
Volume:: 21
Issue:: 5
Pages:: 602-603
Publication date:: 2021-02-15
Acceptance date:: 2021-01-19
DOI:: 10.1016/s1473-3099(21)00053-0
EISSN:: 1474-4457
ISSN:: 1473-3099
Pmid:: 33600759

Language:: English
Keywords:: FFR
Subtype:: Letter
Pubs id:: 1165905
Local pid:: pubs:1165905
Deposit date:: 2021-07-26

Terms of use

Copyright holder:: Elsevier Ltd
Copyright date:: 2021
Rights statement:: © 2021 Elsevier Ltd. All rights reserved.
Notes:: The final version of this article may be available online from the publisher's website.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP